Document Detail

Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
MedLine Citation:
PMID:  11841409     Owner:  NLM     Status:  MEDLINE    
The co-existence of thalassaemia major and chronic myeloid leukaemia (CML) is a very rare event. We report a 32-year-old man with thalassaemia major whose progressively increasing leukocytosis and thrombocytosis led to the diagnosis of CML confirmed by the characteristic t(9;22)(q34;q11) chromosomal translocation and the bcr-abl (b3a2) DNA fusion. The patient was treated with hydroxyurea and anagrelide. This combination resulted in the satisfactory control of both the white blood cell and platelet counts, which has continued over the past 14 months with no major side-effects, albeit with no molecular response. The administration of hydroxyurea was also associated with a significant HbF increase.
Ersi Voskaridou; Evangelos Terpos; Veroniki Komninaka; Eftyhios Eftyhiadis; Marina Mantzourani; Dimitris Loukopoulos
Related Documents :
15860359 - Acquisition of a ph chromosome with minor bcr/abl fusion in treatment-related myelodysp...
19337199 - Chronic myeloid leukemia therapy: focus on second-generation tyrosine kinase inhibitors.
18937509 - Proteomic comparison between two marine snail ecotypes reveals details about the bioche...
18036399 - Confirmation of a novel recurrent association: bcr-abl t(9;22) and t(19;21).
8140859 - Philadelphia chromosome as the sole abnormality and p210 bcr-abl chimeric protein expre...
6578689 - Philadelphia chromosome-negative chronic myelogenous leukemia in a child with t(8;9)(p1...
3366629 - Parallelism between male mating propensity and chromosome arrangement frequency in natu...
3297209 - The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphoma...
23335129 - Neurocognitive variance and neurological underpinnings of the x and y chromosomal varia...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  116     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-02-13     Completed Date:  2002-03-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  155-7     Citation Subset:  IM    
Unit of Thalassaemia, Laikon General Hospital, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antisickling Agents / therapeutic use*
Drug Therapy, Combination
Hydroxyurea / therapeutic use*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood,  complications*,  drug therapy
Leukocyte Count
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Count
Quinazolines / therapeutic use*
Remission Induction
Thrombocytosis / blood,  complications,  drug therapy
beta-Thalassemia / blood,  complications*,  drug therapy
Reg. No./Substance:
0/Antisickling Agents; 0/Platelet Aggregation Inhibitors; 0/Quinazolines; 0/anagrelide; 127-07-1/Hydroxyurea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-ass...
Next Document:  High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor o...